Media

Ironwood Pharmaceuticals is a leading gastrointestinal (GI) healthcare company on a mission to advance the treatment of GI diseases and redefine the standard of care for GI patients.

https://investor.ironwoodpharma.com/press-releases/press-release-details/2021/More-Than-a-Third-of-Surveyed-IBS-C-Patients-Reported-That-Their-Symptoms-Worsened-During-COVID-19-According-to-New-Survey-Findings-Presented-by-Ironwood-Pharmaceuticals-at-Digestive-Disease-Week-DDW/default.aspx

Ironwood has successfully completed the tender offer of VectivBio, a global clinical-stage biotechnology company
pioneering novel, transformational treatments for severe rare gastrointestinal conditions. For more information, click here